BacAlt Biosciences is a first-of-its-kind speciality biotech startup redefining the future of formulations by combining microbiology, precision fermentation and industrial biomanufacturing to deliver performance-first, cost-neutral and sustainable bio-based polymers and speciality ingredients for mass-market applications.
Conventional speciality formulations today rely heavily on synthetic polymers, causing microplastic pollution with severe consequences for human and planetary health—from soil fertility loss and water contamination to food chain disruption and long-term health hazards.
Founded by Shruti Kutmutiya and Dr Pranav Nair, BacAlt is addressing this challenge by developing high-performance bio-based polymers and ingredients using lean, energy-efficient, and high-throughput fermentation that improves end product quality across diverse applications, while simultaneously preventing microplastic pollution.
By leveraging waste valorisation, circular feedstocks, and non-sterile fermentation, BacAlt’s innovative production process sets new performance and cost standards for sustainable materials–providing formulators in home care, personal care, agrochemicals, nutraceuticals, and pharmaceuticals with advanced textures, functionalities, and stability at mass-market viable cost points, reducing reliance on synthetic derivatives.BacalT Logo (1).pngPooja Banthia is the ownerNo changes since you last viewed this fileBacAlt Biosciences is a first-of-its-kind speciality biotech startup redefining the future of formulations by combining microbiology, precision fermentation and industrial biomanufacturing to deliver performance-first, cost-neutral and sustainable bio-based polymers and speciality ingredients for mass-market applications.
